Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 57

1.

Nutritional Status in Childhood as a Prognostic Factor in Patients with Cystic Fibrosis.

Ashkenazi M, Nathan N, Sarouk I, Aluma BEB, Dagan A, Bezalel Y, Keler S, Vilozni D, Efrati O.

Lung. 2019 Jun;197(3):371-376. doi: 10.1007/s00408-019-00218-3. Epub 2019 Mar 18.

PMID:
30887107
2.

Resting Energy Expenditure in Patients With Familial Dysautonomia: A Preliminary Study.

Bar Aluma BE, Norcliffe-Kaufmann L, Sarouk I, Dagan A, Ashkenazi M, Bezalel Y, Vilozni D, Lahad A, Efrati O.

J Pediatr Gastroenterol Nutr. 2019 Mar;68(3):422-427. doi: 10.1097/MPG.0000000000002180.

PMID:
30334929
3.

The Value of Measuring Inspiratory Capacity in Subjects With Cystic Fibrosis.

Vilozni D, Dagan A, Lavie M, Sarouk I, Bar-Aluma BE, Ashkenazi M, Mendelovich SL, Betzalel Y, Efrati O.

Respir Care. 2018 Aug;63(8):981-987. doi: 10.4187/respcare.05920. Epub 2018 Jul 17.

4.

Ivacaftor for the p.Ser549Arg (S549R) gating mutation - The Israeli experience.

Dagan A, Cohen-Cymberknoh M, Shteinberg M, Levine H, Vilozni D, Bezalel Y, Bar Aluma BE, Sarouk I, Ashkenazi M, Lavie M, Tsabari R, Blau H, Kerem E, Bentur L, Efrati O, Livnat G.

Respir Med. 2017 Oct;131:225-228. doi: 10.1016/j.rmed.2017.08.026. Epub 2017 Sep 1.

PMID:
28947035
5.

High Mid-Flow to Vital Capacity Ratio and the Response to Exercise in Children With Congenital Heart Disease.

Vilozni D, Alcaneses-Ofek MR, Reuveny R, Rosenblum O, Inbar O, Katz U, Ziv-Baran T, Dubnov-Raz G.

Respir Care. 2016 Dec;61(12):1629-1635. Epub 2016 Nov 1.

6.

Assessment of Airway Bronchodilation by Spirometry Compared to Airway Obstruction in Young Children with Asthma.

Vilozni D, Hakim F, Livnat G, Ofek M, Bar-Yoseph R, Bentur L.

Can Respir J. 2016;2016:5394876. doi: 10.1155/2016/5394876. Epub 2016 Jun 9.

7.

Consequences of Expiratory Flow Limitation at Rest in Subjects with Cystic Fibrosis.

Vilozni D, Lavie M, Ofek M, Sarouk I, Bar-Aluma BE, Dagan A, Ashkenazi M, Segel MJ, Efrati O.

Ann Am Thorac Soc. 2016 Jun;13(6):825-32. doi: 10.1513/AnnalsATS.201508-485OC.

PMID:
27219817
8.

Glucose intolerance in cystic fibrosis as a determinant of pulmonary function and clinical status.

Lavie M, Fisher D, Vilozni D, Forschmidt R, Sarouk I, Kanety H, Hemi R, Efrati O, Modan-Moses D.

Diabetes Res Clin Pract. 2015 Dec;110(3):276-84. doi: 10.1016/j.diabres.2015.10.007. Epub 2015 Oct 14.

PMID:
26508676
9.

The Short-Term Effect of Breathing Tasks Via an Incentive Spirometer on Lung Function Compared With Autogenic Drainage in Subjects With Cystic Fibrosis.

Sokol G, Vilozni D, Hakimi R, Lavie M, Sarouk I, Bat-El Bar, Dagan A, Ofek M, Efrati O.

Respir Care. 2015 Dec;60(12):1819-25. doi: 10.4187/respcare.04008. Epub 2015 Sep 15.

10.

Cough ability measurements and recurrent respiratory symptoms in individuals with Ataxia Telangiectasia.

Vilozni D, Lavie M, Sarouk I, Levi Y, Alcaneses Ofek MR, Efrati O.

J Asthma. 2016;53(1):37-42. doi: 10.3109/02770903.2015.1032304. Epub 2015 Sep 12.

PMID:
26364772
11.

Nocardia Colonization: A Risk Factor for Lung Deterioration in Cystic Fibrosis Patients?

Dagan A, Keller N, Vilozni D, Ramon-Saraf R, Bar BE, Sarouk I, Ashkenazi M, Lavie M, Efrati O.

Med Sci Monit. 2015 Jun 30;21:1889-94. doi: 10.12659/MSM.893643.

12.

FVC deterioration, airway obstruction determination, and life span in Ataxia telangiectasia.

Vilozni D, Lavie M, Sarouk I, Bar-Aluma BE, Dagan A, Ashkenazi M, Ofek M, Efrati O.

Respir Med. 2015 Jul;109(7):890-6. doi: 10.1016/j.rmed.2015.05.013. Epub 2015 May 21.

13.

Maximal flow at functional residual capacity in asthmatic preschool children.

Vilozni D, Livnat G, Hakim F, Bentur L.

J Asthma. 2015;52(6):560-4. doi: 10.3109/02770903.2014.996652. Epub 2015 Jul 29.

PMID:
25708197
14.

Long-term follow-up of distal intestinal obstruction syndrome in cystic fibrosis.

Lavie M, Manovitz T, Vilozni D, Levy-Mendelovich S, Sarouk I, Weintraubv I, Shoseyov D, Cohen-Cymberknoh M, Rivlin J, Efrati O.

World J Gastroenterol. 2015 Jan 7;21(1):318-25. doi: 10.3748/wjg.v21.i1.318.

15.

Several siblings with Cystic Fibrosis as a risk factor for poor outcome.

Lavie M, Shemer O, Sarouk I, Bar Aluma Be, Dagan A, Efrati O, Vilozni D.

Respir Med. 2015 Jan;109(1):74-8. doi: 10.1016/j.rmed.2014.11.012. Epub 2014 Dec 9.

16.

Cough characteristics and FVC maneuver in cystic fibrosis.

Vilozni D, Lavie M, Ofek M, Sarouk I, Efrati O.

Respir Care. 2014 Dec;59(12):1912-7. doi: 10.4187/respcare.03290. Epub 2014 Sep 23.

17.

Forced expiratory decay in asthmatic preschool children--is it adult type?

Vilozni D, Hakim F, Livnat G, Bentur L.

Respir Med. 2013 Jul;107(7):975-80. doi: 10.1016/j.rmed.2013.03.012. Epub 2013 May 8.

18.

An official American Thoracic Society workshop report: optimal lung function tests for monitoring cystic fibrosis, bronchopulmonary dysplasia, and recurrent wheezing in children less than 6 years of age.

Rosenfeld M, Allen J, Arets BH, Aurora P, Beydon N, Calogero C, Castile RG, Davis SD, Fuchs S, Gappa M, Gustaffson PM, Hall GL, Jones MH, Kirkby JC, Kraemer R, Lombardi E, Lum S, Mayer OH, Merkus P, Nielsen KG, Oliver C, Oostveen E, Ranganathan S, Ren CL, Robinson PD, Seddon PC, Sly PD, Sockrider MM, Sonnappa S, Stocks J, Subbarao P, Tepper RS, Vilozni D; American Thoracic Society Assembly on Pediatrics Working Group on Infant and Preschool Lung Function Testing.

Ann Am Thorac Soc. 2013 Apr;10(2):S1-S11. doi: 10.1513/AnnalsATS.201301-017ST. Review.

PMID:
23607855
19.

Reply: Flow-to-volume "dysanapsis" in cystic fibrosis.

Vilozni D.

Am J Respir Crit Care Med. 2013 Apr 15;187(8):891-2. doi: 10.1164/rccm.201210-1846LE. No abstract available.

PMID:
23586385
20.

Progressive flow-to-volume dysanapsis in cystic fibrosis: a predictor for lung transplantation?

Vilozni D, Lavie M, Sarouk I, Efrati O.

Am J Respir Crit Care Med. 2012 Jul 1;186(1):82-7. doi: 10.1164/rccm.201202-0272OC. Epub 2012 Apr 26.

PMID:
22538801
21.

The effect of beclomethasone dipropionate in ultrafine particles on bronchial hyper-reactivity in young children.

Costa-Katz CL, Livnat G, Hakim F, Vilozni D, Bentur Y, Bentur L.

Acta Paediatr. 2012 May;101(5):e219-24. doi: 10.1111/j.1651-2227.2012.02590.x. Epub 2012 Jan 27.

PMID:
22214276
22.

Hospital versus home treatment of respiratory exacerbations in cystic fibrosis.

Lavie M, Vilozni D, Sokol G, Somech R, Szeinberg A, Efrati O.

Med Sci Monit. 2011 Dec;17(12):CR698-703.

23.

Neurologic presentation in children with ataxia-telangiectasia: is small head circumference a hallmark of the disease?

Nissenkorn A, Levi YB, Vilozni D, Berkun Y, Efrati O, Frydman M, Yahav J, Waldman D, Somech R, Shenhod E, Menascu S, Ben-Zeev B.

J Pediatr. 2011 Sep;159(3):466-471.e1. doi: 10.1016/j.jpeds.2011.02.005. Epub 2011 Mar 22.

PMID:
21429505
24.

Maximal flow at functional residual capacity in healthy children from birth to 7 years, and beyond.

Vilozni D, Bentur L, Godfrey S, Barker M, Bar-Yishay E.

Chest. 2011 Jun;139(6):1439-1444. doi: 10.1378/chest.10-0625. Epub 2010 Oct 7.

PMID:
20930004
25.

The feasibility and validity of forced spirometry in ataxia telangiectasia.

Vilozni D, Berkun Y, Levi Y, Weiss B, Jacobson JM, Efrati O.

Pediatr Pulmonol. 2010 Oct;45(10):1030-6. doi: 10.1002/ppul.21291.

PMID:
20717907
26.

Probiotic supplementation affects pulmonary exacerbations in patients with cystic fibrosis: a pilot study.

Weiss B, Bujanover Y, Yahav Y, Vilozni D, Fireman E, Efrati O.

Pediatr Pulmonol. 2010 Jun;45(6):536-40. doi: 10.1002/ppul.21138.

PMID:
20503277
27.

Outcome of patients with cystic fibrosis admitted to the intensive care unit: is invasive mechanical ventilation a risk factor for death in patients waiting lung transplantation?

Efrati O, Bylin I, Segal E, Vilozni D, Modan-Moses D, Vardi A, Szeinberg A, Paret G.

Heart Lung. 2010 Mar-Apr;39(2):153-9. doi: 10.1016/j.hrtlng.2009.06.014. Epub 2009 Aug 25.

PMID:
20207276
28.

Spirometry follow-up in young children with hemato-oncologic diseases.

Efrati O, Toren A, Duskin H, Goldstein G, Jacobson JM, Churi C, Vilozni D.

Med Sci Monit. 2010 Mar;16(3):MT28-33.

PMID:
20190695
29.

Reversible airway obstruction in children with ataxia telangiectasia.

Berkun Y, Vilozni D, Levi Y, Borik S, Waldman D, Somech R, Nissenkorn A, Efrati O.

Pediatr Pulmonol. 2010 Mar;45(3):230-5. doi: 10.1002/ppul.21095.

PMID:
20146367
30.

Airway reactivity in children before and after stem cell transplantation.

Bentur L, Lapidot M, Livnat G, Hakim F, Lidroneta-Katz C, Porat I, Vilozni D, Elhasid R.

Pediatr Pulmonol. 2009 Sep;44(9):845-50. doi: 10.1002/ppul.20964.

PMID:
19670401
31.

Meconium ileus in patients with cystic fibrosis is not a risk factor for clinical deterioration and survival: the Israeli Multicenter Study.

Efrati O, Nir J, Fraser D, Cohen-Cymberknoh M, Shoseyov D, Vilozni D, Modan-Moses D, Levy R, Szeinberg A, Kerem E, Rivlin J.

J Pediatr Gastroenterol Nutr. 2010 Feb;50(2):173-8. doi: 10.1097/MPG.0b013e3181a3bfdd.

PMID:
19668004
32.

FRC measurements using body plethysmography in young children.

Vilozni D, Efrati O, Hakim F, Adler A, Livnat G, Bentur L.

Pediatr Pulmonol. 2009 Sep;44(9):885-91. doi: 10.1002/ppul.21072.

PMID:
19639626
33.

Spirometry centile charts for young Caucasian children: the Asthma UK Collaborative Initiative.

Stanojevic S, Wade A, Cole TJ, Lum S, Custovic A, Silverman M, Hall GL, Welsh L, Kirkby J, Nystad W, Badier M, Davis S, Turner S, Piccioni P, Vilozni D, Eigen H, Vlachos-Mayer H, Zheng J, Tomalak W, Jones M, Hankinson JL, Stocks J; Asthma UK Spirometry Collaborative Group.

Am J Respir Crit Care Med. 2009 Sep 15;180(6):547-52. doi: 10.1164/rccm.200903-0323OC. Epub 2009 Jul 2.

PMID:
19574442
34.

The potential use of spirometry during methacholine challenge test in young children with respiratory symptoms.

Vilozni D, Livnat G, Dabbah H, Elias N, Hakim F, Bentur L.

Pediatr Pulmonol. 2009 Jul;44(7):720-7. doi: 10.1002/ppul.20978.

PMID:
19499592
35.

The relation between age and time to maximal bronchoconstriction following exercise in children.

Vilozni D, Szeinberg A, Barak A, Yahav Y, Augarten A, Efrati O.

Respir Med. 2009 Oct;103(10):1456-60. doi: 10.1016/j.rmed.2009.04.028. Epub 2009 Jun 3.

36.

Forced inspiratory flow volume curve in healthy young children.

Vilozni D, Efrati O, Barak A, Yahav Y, Augarten A, Bentur L.

Pediatr Pulmonol. 2009 Feb;44(2):105-11. doi: 10.1002/ppul.20835.

PMID:
19142889
37.

Flexible bronchoscopy and bronchoalveolar lavage in pediatric patients with lung disease.

Efrati O, Sadeh-Gornik U, Modan-Moses D, Barak A, Szeinberg A, Vardi A, Paret G, Toren A, Vilozni D, Yahav Y.

Pediatr Crit Care Med. 2009 Jan;10(1):80-4. doi: 10.1097/PCC.0b013e31819372ea.

PMID:
19057431
38.

Reduced vital capacity after methacholine challenge in early childhood--is it due to trapped air or loss of motivation.

Vilozni D, Hakim F, Adler A, Livnat G, Bar-Yishay E, Bentur L.

Respir Med. 2009 Jan;103(1):109-16. doi: 10.1016/j.rmed.2008.07.027. Epub 2008 Sep 19.

39.

Pulmonary function studies in children treated by chemoradiotherapy and stem cell transplantation.

Efrati O, Toren A, Duskin H, Modan-Moses D, Bielorai B, Goldstein G, Churi C, Vilozni D.

Pediatr Blood Cancer. 2008 Nov;51(5):684-8. doi: 10.1002/pbc.21722.

PMID:
18698587
40.

Hemoptysis in Israeli CF patients--prevalence, treatment, and clinical characteristics.

Efrati O, Harash O, Rivlin J, Bibi H, Meir MZ, Blau H, Mussaffi H, Barak A, Levy I, Vilozni D, Kerem E, Modan-Moses D.

J Cyst Fibros. 2008 Jul;7(4):301-6. doi: 10.1016/j.jcf.2007.11.007. Epub 2008 Jan 9.

41.

Exercise challenge test in 3- to 6-year-old asthmatic children.

Vilozni D, Bentur L, Efrati O, Barak A, Szeinberg A, Shoseyov D, Yahav Y, Augarten A.

Chest. 2007 Aug;132(2):497-503. Epub 2007 Jun 15.

PMID:
17573494
42.

An official American Thoracic Society/European Respiratory Society statement: pulmonary function testing in preschool children.

Beydon N, Davis SD, Lombardi E, Allen JL, Arets HG, Aurora P, Bisgaard H, Davis GM, Ducharme FM, Eigen H, Gappa M, Gaultier C, Gustafsson PM, Hall GL, Hantos Z, Healy MJ, Jones MH, Klug B, Lødrup Carlsen KC, McKenzie SA, Marchal F, Mayer OH, Merkus PJ, Morris MG, Oostveen E, Pillow JJ, Seddon PC, Silverman M, Sly PD, Stocks J, Tepper RS, Vilozni D, Wilson NM; American Thoracic Society/European Respiratory Society Working Group on Infant and Young Children Pulmonary Function Testing.

Am J Respir Crit Care Med. 2007 Jun 15;175(12):1304-45. Review. No abstract available.

PMID:
17545458
43.

Spirometry in early childhood in cystic fibrosis patients.

Vilozni D, Bentur L, Efrati O, Minuskin T, Barak A, Szeinberg A, Blau H, Picard E, Kerem E, Yahav Y, Augarten A.

Chest. 2007 Feb;131(2):356-61.

PMID:
17296633
44.

The effect of montelukast on bronchial hyperreactivity in preschool children.

Hakim F, Vilozni D, Adler A, Livnat G, Tal A, Bentur L.

Chest. 2007 Jan;131(1):180-6.

PMID:
17218573
45.

The role of computer games in measuring spirometry in healthy and "asthmatic" preschool children.

Vilozni D, Barak A, Efrati O, Augarten A, Springer C, Yahav Y, Bentur L.

Chest. 2005 Sep;128(3):1146-55.

PMID:
16162700
46.

Methacholine bronchial provocation measured by spirometry versus wheeze detection in preschool children.

Bentur L, Beck R, Elias N, Barak A, Efrati O, Yahav Y, Vilozni D.

BMC Pediatr. 2005 Jun 28;5:19.

47.

Liver cirrhosis and portal hypertension in cystic fibrosis.

Efrati O, Barak A, Modan-Moses D, Augarten A, Vilozni D, Katznelson D, Szeinberg A, Yahav J, Bujanover Y.

Eur J Gastroenterol Hepatol. 2003 Oct;15(10):1073-8.

PMID:
14501614
48.

Lung function in preschool children.

Vilozni D, Efrati O, Barak A.

Thorax. 2003 May;58(5):461-2. No abstract available.

49.

An interactive computer-animated system (SpiroGame) facilitates spirometry in preschool children.

Vilozni D, Barker M, Jellouschek H, Heimann G, Blau H.

Am J Respir Crit Care Med. 2001 Dec 15;164(12):2200-5.

PMID:
11751188
50.

Evaluation of a commercial infant body plethysmography.

Kusenbach G, Pott H, Breuer A, Pfannenstiel C, Barker M, Michailidis K, Heimann G, Vilozni D.

Eur Respir J. 1998 May;11(5):1211-3. No abstract available.

Supplemental Content

Loading ...
Support Center